Open AccessLactobacillus rhamnosus GG Improves Outcome in Experimental Pseudomonas aeruginosa Pneumonia
Author(s) -
Ludmila Khailová,
Christine Baird,
Aubri A. Rush,
Eóin N. McNamee,
Paul E. Wischmeyer
Publication year - 2013
Publication title -
shock
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.095
H-Index - 117
eISSN - 1540-0514
pISSN - 1073-2322
DOI - 10.1097/shk.0000000000000066
Subject(s) - lactobacillus rhamnosus , pneumonia , pseudomonas aeruginosa , medicine , bronchoalveolar lavage , immunology , probiotic , immune system , flow cytometry , lung , foxp3 , biology , bacteria , genetics
Recent clinical trials show Lactobacillus rhamnosus GG (LGG) administration in critical illness has the potential to reduce nosocomial infections and improve clinical outcome. However, the mechanism(s) of LGG-mediated benefit following illness and injury remain elusive.